Bring more to life.
Are you ready to accelerate your potential and make a real difference within life sciences, diagnostics and biotechnology?
At Radiometer, one of Danaher’s 15+ operating companies, our work saves lives— and we’re all united by a shared commitment to innovate for tangible impact.
You’ll thrive in a culture of belonging where you and your unique viewpoint matter. And by harnessing Danaher’s system of continuous improvement, you help turn ideas into impact – innovating at the speed of life.
At Radiometer, life comes first. Our vision is to improve global healthcare with reliable, fast, and easy patient diagnoses. We’re a team that celebrates diverse ideas and continuous improvement. Here, you’ll find a place to grow and make a real impact, with your unique perspective driving us forward in improving patient care. At Radiometer, our vision is to improve global healthcare with reliable, fast, and easy patient diagnoses.
Learn about the Danaher Business System which makes everything possible.
The Senior Innovation Manager (Early Product Development & Assessment) is responsible for shaping Radiometer’s future product pipeline by leading the structured evaluation of early-stage innovation opportunities.
The role drives evidence-based decision-making by assessing clinical value, market potential, and strategic fit, while translating customer needs into actionable concepts. Working cross-functionally, the Senior Innovation Manager ensures that only the most impactful and viable ideas progress into development, enabling a focused, high-quality innovation portfolio aligned with company strategy.
This position reports to the Director, Strategic Portfolio & Innovation Management and is part of the Global Product & Portfolio Management team. This is a remote position with regular travel required to Radiometer’s headquarters in Copenhagen, Denmark.
In this role, you will have the opportunity to:
Shape the future innovation pipeline by leading early-stage evaluation of new product ideas across Radiometer’s portfolio (ABL, AQT, Digital, VET, and beyond).
Drive evidence-based decision-making by applying structured assessment frameworks (clinical value, market potential, technical feasibility, strategic fit, financial attractiveness). This includes construction of financial models and sensitivity analyses required for decision-grade business cases.
Lead front-end innovation activities including opportunity identification, concept validation, and market assessment to ensure focus on high-impact growth areas.
Translate customer needs into early concepts by defining and guiding Voice of Customer (VoC) activities, synthesizing insights into concepts and value propositions.
Collaborate cross-functionally with R&D, PMO, Regulatory Affairs, Medical Affairs, Operations, Legal, and regional teams to align early development with company, commercial and clinical realities.
Challenge and refine innovation ideas by stress-testing assumptions, identifying risks and value drivers, and ensuring robust business cases before development investments.
The essential requirements of the job include:
Master’s degree in Engineering, Life Sciences, Biomedical, or Business/Economics (or equivalent experience)
Long-standing product innovation experience within in vitro diagnostics, medical devices, or closely related healthcare technology
Demonstrated experience leading ideation, de-risking and assessments of new product ideas
Demonstrated strategic thinking, analytical rigor (with financial modelling and scenario analysis) and navigating uncertainty with confidence
Demonstrated ability to own end-to-end business case inputs and outputs, with full accountability for data accuracy and defensibility.
Travel Requirements:
It would be a plus if you also possess previous experience in:
Advanced degree (PhD or MBA), particularly in healthcare technology, product management, or market strategy
Prior experience within acute care or point-of-care diagnostics
Experience with Danaher Business System (DBS) or equivalent lean/continuous improvement methodology
Knowledge of IVD regulatory frameworks (IVDR, FDA 510(k)) and their implications for product strategy
Application
Please note that due to the summer holiday period, our response times may be slightly longer than usual.
We appreciate your patience and understanding, and we look forward to receiving your application.
Danaher
Join our winning team today. Together, we’ll accelerate the real-life impact of tomorrow’s science and technology. We partner with customers across the globe to help them solve their most complex challenges, architecting solutions that bring the power of science to life.
For more information, visit .
Danaher is a global conglomerate with 15+ operating companies across life sciences, diagnostics, and biotechnology. The company operates through subsidiaries including Cytiva, Aldevron, and Beckman Coulter Diagnostics, which collectively develop and deliver innovative solutions for clinical diagnostics, bioprocess manufacturing, and therapeutic development. Cytiva specializes in bioprocess filtration technologies and solutions for vaccine and drug manufacturing, while Beckman Coulter Diagnostics is a global leader in clinical diagnostics with systems used in hospitals and laboratories worldwide, running over one million tests per hour and impacting 1.2 billion patients annually. Aldevron provides world-class CDMO services for genomic medicine and cell and gene therapies. Danaher's mission is centered on continuous improvement through the Danaher Business System, enabling innovation at scale to advance human health and save lives.
